<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03254550</url>
  </required_header>
  <id_info>
    <org_study_id>Swazi PrEP study</org_study_id>
    <nct_id>NCT03254550</nct_id>
  </id_info>
  <brief_title>PrEP Demonstration Study in Swaziland</brief_title>
  <official_title>Expanding Options for HIV Prevention Through Pre-exposure Prophylaxis in Hhohho Region, Swaziland</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Clinton Health Access Initiative Inc.</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Ministry of Health, Swaziland</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Heidelberg University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Mylan Laboratories</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Clinton Health Access Initiative Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      An 18 month observation cohort study with the overall aim to assess the operationalization of
      oral Pre-exposure prophylaxis (PrEP) in Swaziland as an additional HIV combination prevention
      method among population groups and individuals at high risk of HIV infection.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This PrEP demonstration project will have two periods: a 12 month enrolment period and a 6
      month follow-up period. The study will assess who will be reached with an introduction to and
      an offer of PrEP - and who will take up PrEP - when PrEP becomes available through different
      delivery points in the public-sector health system, including outpatient department (OPD),
      antenatal care (ANC), postnatal care (PNC) , family planning (FP) , and following HIV
      counseling and testing (VCT).

      In addition to PrEP reach and PrEP uptake, the study aims to establish PrEP retention and
      average costs per client, by different health systems delivery points and to assess the
      effectiveness and cost-effectiveness of a feasible and low-cost PrEP Promotion Package (PPP).
      The exact composition of PPP will be informed by findings from in-depth- interviews with
      clients, providers, and PrEP stakeholders as well as from focus group discussions with
      community members to ensure the PPP will be feasible, effective and portends sustainability.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 1, 2017</start_date>
  <completion_date type="Anticipated">January 31, 2019</completion_date>
  <primary_completion_date type="Anticipated">July 31, 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Uptake</measure>
    <time_frame>12 months</time_frame>
    <description>% of HIV negative clients at substantial risk for HIV infection who accept a PrEP offer</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Linkage</measure>
    <time_frame>12 months</time_frame>
    <description>% of clients who either take up PrEP (if HIV negative) or are linked to Antiretroviral therapy (if HIV positive)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Retention at 6 months</measure>
    <time_frame>6 months</time_frame>
    <description>% of HIV negative clients at substantial risk for HIV infection who are retained on PrEP 6 months after initiation.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>HIV incidence</measure>
    <time_frame>18 month</time_frame>
    <description>% of clients on PrEP who seroconvert</description>
  </secondary_outcome>
  <enrollment type="Anticipated">538</enrollment>
  <condition>HIV Negative People Identified at Substantial Risk for HIV Infection</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>PrEP Promotion Package</intervention_name>
    <description>A PrEP promotion package will be developed to test if this will change uptake, acceptance, retention and PrEP knowledge</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        HIV negative people &gt; 16 years, utilizing public health sector in Swaziland
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Confirmed HIV negative by rapid antibody test following the National HIV testing
             services (HTS) algorithm on the day of PrEP initiation

          -  &gt; 16 years of age

          -  Willing and able to provide written informed consent

          -  Identified at substantial risk of acquiring HIV infection

          -  No current or recent illness (within past month) consistent with acute HIV infection
             in combination with a preceding high risk exposure for HIV

          -  No contraindications to the use of Tenofovir(TDF)/Lamivudine (3TC)

          -  Ready to adhere to PrEP and willing to attend the follow up evaluations including
             repeat HIV testing and monitoring for side-effects

        Exclusion Criteria:

          -  Younger than 16 years of age

          -  Currently having symptoms of acute HIV infection

          -  Suspicion of window period following a potential exposure to HIV

          -  Body weight &lt; 40 kg

          -  Creatinine clearance &lt;60 ml/min

          -  Using other nephrotoxic drugs (e.g. aminoglycosides)

          -  Not willing to come for follow up visits every 3 months which will include HIV testing
             and counselling and monitoring for side-effects.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>16 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Anita Hettema, MPH</last_name>
    <phone>+26876751498</phone>
    <email>ahettema@clintonhealthaccess.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Charlotte Lejeune, BA</last_name>
    <phone>+26876298347</phone>
    <email>clejeune@clintonhealthaccess.org</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hhukwini Clinic</name>
      <address>
        <city>Hhukwini</city>
        <state>Hhohho region</state>
        <country>Swaziland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sindy Matse, MPH</last_name>
      <phone>+26876289474</phone>
      <email>matsesindy@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Horo Clini</name>
      <address>
        <city>Horo</city>
        <state>Hhohho region</state>
        <country>Swaziland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sindy Matse, MPH</last_name>
      <phone>+26876289474</phone>
      <email>matsesindy@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ndvwabangeni Nazarene Clinic</name>
      <address>
        <city>Ndvwabangeni</city>
        <state>Hhohho Region</state>
        <country>Swaziland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sindy Matse, MPH</last_name>
      <phone>+26876289474</phone>
      <email>matsesindy@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ndzingeni Nazarene Clinic</name>
      <address>
        <city>Ndzingeni</city>
        <state>Hhohho Region</state>
        <country>Swaziland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sindy Matse, MPH</last_name>
      <phone>+26876289474</phone>
      <email>matsesindy@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Nfontjeni Clinic</name>
      <address>
        <city>Nfontjeni</city>
        <state>Hhohho Region</state>
        <country>Swaziland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sindy Matse, MPH</last_name>
      <phone>+26876289474</phone>
      <email>matsesindy@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Siphocosini Clinic</name>
      <address>
        <city>Siphocosini</city>
        <state>Hhohho region</state>
        <country>Swaziland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sindy Matse, MPH</last_name>
      <phone>+26876289474</phone>
      <email>matsesindy@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Swaziland</country>
  </location_countries>
  <verification_date>August 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 17, 2017</study_first_submitted>
  <study_first_submitted_qc>August 17, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">August 18, 2017</study_first_posted>
  <last_update_submitted>August 17, 2017</last_update_submitted>
  <last_update_submitted_qc>August 17, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">August 18, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>PrEP</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>HIV Infections</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

